Back

The early evaluation of diuretic resistance as recommended by ESC Guidelines predicts long-term outcomes in patients with acute heart failure.

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - clinical 1 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Juan Carlos Lopez Azor

Hospital Universitario Puerta de Hierro, Majadahonda (Spain)

7 More presentations in this session

Presentation thumbnail
Sex and gender differences in characteristics, treatment, and short-term prognosis among patients with acute myocarditis in Korea
Doctor M. Kim (Seoul, KR)
Abstract Slides
Presentation thumbnail
Impact of cardiac sarcoidosis on admissions for acute-on-chronic combined systolic and diastolic heart failure
Mr G. Yeap (GB)
Abstract Slides Video
Presentation thumbnail
A multi-centre audit on the impact of optimal guideline directed medical therapy (GDMT) on left ventricular ejection fraction (LVEF) in Irish heart failure nurse-led clinics.
Ms J. Aherne (Cork, IE)
Abstract Slides Video
Presentation thumbnail
Congestion as a crucial factor determining albuminuria in in patients with cardiorenal disease
Doctor P. Llacer (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
The association between body mass index and right ventricular dysfunction in orthopedic trauma
Associate Professor H. Kim (Guri, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure - clinical 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Early assessment of diuretic resistance: predictive factors and impact on outcomes of patients with acute heart failure.
thumbnail
Congress Presentation
Acute heart failure patients with diuretic resistance: who are they and prognostic implications of diuretic resistance. The experience of a general hospital
thumbnail
Congress Presentation
Diuretic resistance and the efficacy of hydrochlorothiazide in acute decompensated heart failure: a post-hoc analysis of the CLOROTIC Trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources